Could Naloxone Improve Survival Rates in Cardiac Arrest Patients?
Surprisingly, naloxone was associated with improved clinical outcomes in both drug-related cardiac arrests and non-drug-related cardiac arrests.
Tag: Narcan naloxone
All
Latest
All
LatestFDA Approves Narcan Nasal Spray for OTC Use
The FDA approved Narcan 4 mg naloxone hydrochloride nasal spray for over-the-counter, nonprescription use. The approval is the first for a naloxone product without a prescription.
All
Latest
Evzio Naloxone Auto-injector and Generic Discontinued
Kaleo Inc has discontinued its naloxone hydrochloride injection product Evzio and its authorized generic, according to industry reports.
FDA Rebuts Criticism of Approval Process for Inhaled Naloxone Spray
An FDA director responded to criticism over the agency’s approval process of the nasal spray naloxone (Narcan), an opioid overdose reversal agent intended to be administered by EMS personnel.
Read MoreFDA Approves Narcan Nasal Spray for Opioid Overdose
Narcan is the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose.
Read More
Stimulant Reverses, Prevents Opioid-induced Respiratory Depression
A new therapeutic drug, GAL-021, may reverse or prevent respiratory depression, or inadequate breathing, in patients taking opioid medication without compromising pain relief or increasing sedation.
Read More
Opioid Overdose Treatment Evzio Available in US
Kaleo has launched US commercial availability of Evzio for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.
Read More
FDA Approves Evzio for Opioid Overdose
The US FDA approved Evzio (naloxone hydrochloride injection) for the emergency treatment of known or suspected opioid overdose by for immediate administration by family members or caregivers for suspected opioid overdose.
Read More